
    
      Subjects meeting all of the following criteria will be considered for enrolment into the
      study.

        1. Histologically documented colorectal adenocarcinoma

        2. Previous chemotherapy up to two regimens(including adjuvant chemotherapy and first-line
           chemotherapy without oxaliplatin) is allowed in phase I portion; patients are required
           to have discontinued chemotherapy and/or radiotherapy for at least 4weeks before entry
           into phase I portion. No prior chemotherapy or radiotherapy allowed(adjuvant
           chemotherapy and/or radiotherapy would be allowed) in phase II portion

        3. Age 18 to 75 years old

        4. At least one unidimensional measurable lesion with a diameter >20 mm using conventional
           CT or MRI scans or >10 mm using spiral CT scans (use of spiral CT must be documented in
           medical records and used consistently throughout study).

        5. In phase I study, prior radiotherapy is permitted if it was not administered to target
           lesions selected for this study, unless progression of the selected target lesions
           within the radiation portal is documented, and provided it has been completed at least 4
           weeks before study entry.

        6. Performance status (ECOG scale): 0-2

        7. Patients can take food and drugs orally

        8. Adequate organ functions

        9. Life expectancy â‰¥ 3 months

       10. Written informed consent
    
  